Topic

Uptravi (selexipag)

A collection of 37 issues

How to Get Uptravi (Selexipag) Covered by Humana in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Uptravi Coverage To get Uptravi (selexipag) covered by Humana in Pennsylvania, you need prior authorization with specific documentation. Most approvals require: confirmed WHO Group I PAH by right heart catheterization, documented failure of at least two other PAH therapies, and a specialist's prior

How to Get Uptravi (Selexipag) Covered by Blue Cross Blue Shield in New Jersey: Complete Coverage Guide

Quick Answer: To get Uptravi (selexipag) covered by Blue Cross Blue Shield in New Jersey, you'll need prior authorization with WHO Group I PAH diagnosis, right heart catheterization results, 6-minute walk test, and WHO functional class documentation. Submit through Horizon BCBS portal or CoverMyMeds. If denied, use New

Work With Your Doctor to Get Uptravi (selexipag) Approved by Cigna in Florida: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Uptravi (selexipag) Approved by Cigna in Florida Eligibility: You need confirmed WHO Group I pulmonary arterial hypertension (PAH) with documented right heart catheterization and prior/ongoing background therapy (ERA, PDE5 inhibitor, or prostacyclin). Fastest path: Work with your PAH specialist to submit complete documentation through Cigna'

How to Get Uptravi (selexipag) Covered by Aetna (CVS Health) in California: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Uptravi (selexipag) Covered by Aetna (CVS Health) in California Uptravi (selexipag) requires prior authorization from Aetna (CVS Health) with strict clinical criteria. You'll need a pulmonologist or cardiologist to prescribe it, documented WHO Group I PAH diagnosis, and often proof of trying other PAH medications

How to Get Uptravi (Selexipag) Covered by UnitedHealthcare in New York: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Uptravi Covered by UnitedHealthcare in New York Uptravi (selexipag) requires prior authorization from UnitedHealthcare for pulmonary arterial hypertension (PAH) patients in New York. Your fastest path to approval: 1. Confirm WHO Group I PAH diagnosis with right heart catheterization results 2. Document step therapy (failed PDE5 inhibitors

How Long Does It Take to Get Uptravi (Selexipag) Approved by Blue Cross Blue Shield in Georgia? Timeline & Milestones

Answer Box: Uptravi Approval Timeline in Georgia Blue Cross Blue Shield Georgia typically processes Uptravi (selexipag) prior authorization requests within 5-7 business days for standard reviews, or 72 hours for expedited cases. Success depends on complete documentation of WHO Group I PAH diagnosis, background therapy failures, and specialist prescriber credentials.

How to Get Uptravi (Selexipag) Covered by Aetna CVS Health in Texas: Complete PA Guide and Appeals Process

Answer Box: Getting Uptravi (Selexipag) Covered by Aetna CVS Health in Texas Eligibility: Aetna CVS Health requires prior authorization for Uptravi (selexipag) with strict documentation: WHO Group I PAH diagnosis, right heart catheterization results, functional class II-IV status, and failure of 2+ oral PAH therapies (60 days each). Fastest path:

How to Get Uptravi (Selexipag) Covered by UnitedHealthcare in Washington: Forms, Appeals & Contacts

Answer Box: Getting Uptravi Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization for Uptravi (selexipag) in Washington. The fastest path to approval: 1) Verify your plan's formulary status and PA requirements through the UnitedHealthcare provider portal, 2) Submit complete clinical documentation including confirmed WHO Group I PAH

Coding That Helps Get Uptravi (selexipag) Approved by Aetna (CVS Health) in North Carolina: ICD-10, J-Codes & NDC Requirements

Answer Box Getting Uptravi (selexipag) covered by Aetna (CVS Health) in North Carolina requires precise coding and comprehensive documentation. Use ICD-10 codes I27.0 (primary PAH) or I27.21 (secondary PAH) with WHO Group I confirmation via right heart catheterization. Bill IV formulations using J3490 + NDC on medical benefit; oral

If Uptravi (Selexipag) Isn't Approved by UnitedHealthcare in North Carolina: Formulary Alternatives & Exception Paths

Answer Box: When UnitedHealthcare Denies Uptravi (Selexipag) in North Carolina UnitedHealthcare requires step therapy before approving Uptravi (selexipag) for pulmonary arterial hypertension. You'll need to try formulary alternatives first—typically PDE5 inhibitors (sildenafil, tadalafil) or endothelin receptor antagonists (ambrisentan, bosentan)—unless you qualify for an exception. If denied